Results Regardless of age, an increasing trend in patient volume was observed in the Southern US region, which accounted for 50.7–56.9% of onychomycosis patients in 2022.
← all excerpts
Patient Characteristics, Diagnostic Testing Utilization, and Antifungal Prescribing Pattern for Onychomycosis in the USA: A Cohort Study Using DataDerm, 2016-2022.
1
—
—